FDA Disputes Claims that it Prematurely Updated Plavix Label with PGx Information
March 28, 2012
FDA Disputes Claims that it Prematurely Updated Plavix Label with PGx Information
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- UF to Genotype All Comers at Cath Lab to Personalize Treatment with Plavix, Eventually Other Drugs
June 27, 2012 / Pharmacogenomics Reporter - Dx Developers' Sales Pitch to Pharma Could be Key Factor in Marketing Some Tests
February 15, 2012 / Pharmacogenomics Reporter - Former FDA Official Larry Lesko to Lead Pharmacology, Personalized Rx Studies at U of Florida
October 5, 2011 / Pharmacogenomics Reporter - Nanosphere Will Submit Troponin Assay to FDA This Year, Expand European Launch
May 3, 2011 / BioArray News - AutoGenomics Launches Familial Mediterranean Fever Panel, Plans FDA Submission
January 25, 2011 / BioArray News